Clinical Trial Update: Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia [Phase 1]

View source ↗

Summary

This update reports results from a Phase 1 trial evaluating pomalidomide in patients with relapsed or refractory Waldenström macroglobulinemia; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Waldenstrom Macroglobulinemia, Refractory Waldenstrom Macroglobulinemia | Phase 1 | Status: TERMINATED | Results posted: 2025-09-04